Business Standard

Board of ANG Lifesciences India approves acquisition majority stake in Baddi Agro

Image

Capital Market

At meeting held on 08 November 2021

The Board of ANG Lifesciences India at its meeting held on 08 November 2021 has decided to invest in the Equity Shares and Redeemable Cumulative Preference Shares of Baddi Agro. Consequent to the acquisition of 51% Equity stake by the Company, Baddi Agro will become the Subsidiary Company of ANG Lifesciences India.

Baddi Agro has manufacturing unit situated at Baddi Himachal Pradesh (formerly known as Surya Pharmaceutical) which is laced with latest machinery and located proximate to Mentha Leaf cultivation area.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 09 2021 | 12:57 PM IST

Explore News